BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37705411)

  • 1. Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database.
    McMurtry V; Cleary AS; Ruano AL; Lomo L; Gulbahce HE
    Am J Clin Oncol; 2023 Dec; 46(12):559-566. PubMed ID: 37705411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
    Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
    Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
    Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
    BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
    Yang X; Tang T; Zhou T
    World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
    Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
    Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
    Nelson RA; Guye ML; Luu T; Lai LL
    Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
    Cao AY; He M; Huang L; Shao ZM; Di GH
    World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metaplastic breast cancer: clinicopathological features and its prognosis.
    Lee H; Jung SY; Ro JY; Kwon Y; Sohn JH; Park IH; Lee KS; Lee S; Kim SW; Kang HS; Ko KL; Ro J
    J Clin Pathol; 2012 May; 65(5):441-6. PubMed ID: 22412048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic heterogeneity predicts patient prognosis of HER2-positive metastatic breast cancer: A retrospective study based on SEER database.
    Wang Y; Liang Y; Ye F; Luo D; Jin Y; Li Y; Zhao W; Chen B; Wang L; Yang Q
    Cancer Med; 2023 Sep; 12(18):18597-18610. PubMed ID: 37605516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
    Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
    Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
    Chen S; Wang J; Yang L; Ji M; Chen S
    J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique characteristics and failure patterns of metaplastic breast cancer in contrast to invasive ductal carcinoma: a retrospective multicenter case-control study (KROG 13-07).
    Yu JI; Choi DH; Huh SJ; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Kim JH; Cho J; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Apr; 15(2):e105-15. PubMed ID: 25459069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes.
    Wang J; He ZY; Dong Y; Sun JY; Zhang WW; Wu SG
    Front Genet; 2018; 9():638. PubMed ID: 30619463
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
    Roberts MC; Miller DP; Shak S; Petkov VI
    Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.